PRODUCTS

DOCOSAPENTAENOIC ACID

Docosapentaenoic Acid has applications in sports nutrition to support muscle recovery and reduce exercise-induced inflammation.
In cosmetic and dermatological products, docosapentaenoic acid is used for its skin barrier–supporting and anti-inflammatory properties.
Docosapentaenoic Acid is also used in aquaculture and animal feed formulations to improve growth, health, and fatty acid profiles of farmed species.

CAS Number: 24880-45-3 (for the n-3 isomer)
IUPAC Name: (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoic acid
Molecular Formula: C₂₂H₃₄O₂
Molecular Weight: ~330.5 g/mol

SYNONYMS:
Docosapentaenoic acid, DPA, n-3 DPA, clupanodonic acid, 22:5(n-3) fatty acid, (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoic acid, omega-3 docosapentaenoic acid, For the omega-6 isomer: osbond acid, all-cis-4,7,10,13,16-docosapentaenoic acid, 22:5(n-6) fatty acid, docosapentaenoic acid, fatty acid 22:5, RefChem:135375, CHEBI:61204, DTXSID90865221, CHEBI:132543, docosapentaenoic acid (C22:5 N6), docosa-4,7,10,13,16-pentaenoic acid, (all-Z)-, 25448-00-4, 2E,4E,6E,8E,10E-docosapentaenoic acid, 24880-45-3, Clupanodonic acid, (7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoic acid, all-cis-7,10,13,16,19-Docosapentaenoic acid, cis-7,10,13,16,19-Docosapentaenoic acid, 7Z,10Z,13Z,16Z,19Z-Docosapentaenoic acid, (all Z)-7,10,13,16,19-Docosapentaenoic acid, (all-cis)-7,10,13,16,19-Docosapentaenoic Acid, Docosapentaenoic acid (22n-3), MFCD00156103, NS3OZT14QT, (7Z,10Z,13Z,16Z,19Z)-Docosapentaenoic acid, 7,10,13,16,19-docosapentaenoic acid, (7Z,10Z,13Z,16Z,19Z)-, 7,10,13,16,19-Docasapentaenoic acid, (all-Z)-, Docosapentaenoic acid 22n-3, CHEMBL496634, FA 22:5, UNII-NS3OZT14QT, (all-Z)-7, 10, 13, 16, 19-docosapentaenoic acid, Clupanodonate, Docosapentaenoic, Osbond's acid, 7,10,13,16,19-Docosapentaenoic acid, (all Z)-, SCHEMBL20748, BSPBio_001300, BML3-C02, orb1307078, orb3025604, DTXSID6074758, CHEBI:53488, MSK1764, HMS1361A22, HMS1791A22, HMS1989A22, HMS3402A22, HMS3649F13, docosapentaenoic acid (C22:5 N3), BDBM50269224, LMFA04000044, 7,10,13,16,19-docosapentaenoate, AKOS027382354, DOCOSAPENTAENOIC ACID [WHO-DD], IDI1_033770, NCGC00161353-01, NCGC00161353-02, NCGC00161353-03, BP-40903, HY-113159, CS-0062313, Docosa-7c,10c,13c,16c,19c-pentaensaeure, C22:5 (N-3), Delta7,10,13,16,19-Docosapentaenoic acid, docosa-7Z,10Z,13Z,16Z,19Z-pentaenoic acid, G12426, (all-Z)-7,10,13,16,19-Docosapentaenoic acid, SR-01000946652, 22:5 N-3, Q3278345, SR-01000946652-1, FA(22:5(7Z,10Z,13Z,16Z,19Z)), 7(Z),10(Z),13(Z),16(Z),19(Z)-Docosapentaenoic acid, 7,10,13,16,19-Docosapentaenoic acid, (all-Z)- (8CI), (7Z,10Z,13Z,16Z,19Z)-Docosa 7,10,13,16,19-pentaenoate, (7Z,10Z,13Z,16Z,19Z)-Docosa 7,10,13,16,19-pentaenoic acid, (7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoicacid, 7,10,13,16,19-Docosapentaenoicacid,(7Z,10Z,13Z,16Z,19Z)-, all-cis-7,10,13,16,19-Docosapentaenoic acid, synthetic, >=97%, 7,10,13,16,19-Docosapentaenoic acid, (7Z,10Z,13Z,16Z,19Z)- (9CI), 244880-45-3, 32839-34-2, Docosapentaenoic acid (cis-7,10,13,16,19), 500 mug/mL in ethanol, certified reference material, (7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoic acid, (all Z)-7,10,13,16,19-Docosapentaenoic acid, all-cis-7,10,13,16,19-Docosapentaenoic acid, cis-7,10,13,16,19-Docosapentaenoic acid, Clupanodonic acid, Docosa-7Z,10Z,13Z,16Z,19Z-pentaenoic acid, Docosapentaenoic acid, DPA, DPAn-3, 7Z,10Z,13Z,16Z,19Z-Docosapentaenoic acid, (7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoate, (all Z)-7,10,13,16,19-Docosapentaenoate, all-cis-7,10,13,16,19-Docosapentaenoate, cis-7,10,13,16,19-Docosapentaenoate, Clupanodonate, Docosa-7Z,10Z,13Z,16Z,19Z-pentaenoate, Docosapentaenoate, 7Z,10Z,13Z,16Z,19Z-Docosapentaenoate, Docosapentaenoate (22N-3), 7,10,13,16,19-Docosapentaenoic acid, (all-Z)-isomer, Docosapentaenoic acid (C22:5 N3), Osbond acid, (all-Z)-7, 10, 13, 16, 19-Docosapentaenoic acid, 7,10,13,16,19-Docosapentaenoic acid, Docosapentaenoic acid, (all Z)-isomer, (7Z,10Z,13Z,16Z,19Z)-Docosa 7,10,13,16,19-pentaenoate, (7Z,10Z,13Z,16Z,19Z)-Docosa 7,10,13,16,19-pentaenoic acid, 7,10,13,16,19-Docosapentaenoate, FA(22:5(7Z,10Z,13Z,16Z,19Z)), (7Z,10Z,13Z,16Z,19Z)-7,10,13,16,19-Docosapentaenoic acid, (all-Z)-7,10,13,16,19-Docosapentaenoic acid, FA(22:5n3), delta7,10,13,16,19-Docosapentaenoic acid, omega3-Docosapentaenoic acid, Δ7,10,13,16,19-Docosapentaenoic acid, ω3-Docosapentaenoic acid

Docosapentaenoic Acid is a lesser-known omega-3 fatty acid that serves as an intermediary between EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in the long-chain omega-3 metabolic pathway.
Structurally, Docosapentaenoic Acid is a 22-carbon polyunsaturated fatty acid with five double bonds, and is sometimes referred to as omega-3 DPA to distinguish it from omega-6 DPA (docosapentaenoic acid n-6), which has different biological effects.

Docosapentaenoic Acid is a polyunsaturated very long-chain fatty acid with a 22-carbon backbone and exactly 5 double bonds.
There are 3 recognized isomers of docosapentaenoic acid, and double-bonds for this fatty acid can be originating from either the (3rd, 6th, 9th, 12th, and 15th), the (3rd, 7th, 10th, 14th, and 18th), or the (6th, 9th, 12th, 15th, and 18th) positions from the methyl end.

Docosapentaenoic Acid is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication.
Docosapentaenoic acid (22n-3) (also known as clupanodonic acid) is an essential omega-3 fatty acid (EFA) which is prevalent in fish oils.
Docosapentaenoic acid, commonly called DPA, is an intermediary between eicosapentaenoic acid (EPA, 20:5 ω-3) and docosahexaenoic acid (DHA, 22:6 ω-3).

Seal oil is a rich source of this metabolite.
There are three functions of docosapentaenoic acid.
Most importantly, it is a component of phospholipids found in all animal cell membranes, and a deficiency of docosapentaenoic acid leads to faulty membranes being formed.

Secondly, Docosapentaenoic Acid is involved in the transport and oxidation of cholesterol, and clupanodonic acid tends to lower plasma cholesterol.
A third function is as a precursor of prostanoids which are only formed from docosapentaenoic acid.

Deficiency of this in experimental animals causes lesions mainly attributable to faulty cellular membranes.
Outcomes include sudden failure of growth, lesions of the skin, kidney, and connective tissue, erythrocyte fragility, impaired fertility, and the uncoupling of oxidation and phosphorylation.

In humans, pure deficiency of docosapentaenoic acid has been studied particularly in persons fed intravenously.
A relative deficiency (that is, a low ratio in the body of docosapentaenoic to long-chain saturated fatty acids and isomers of docosapentaenoate) is common in Western diets and plays an important part in the causation of atherosclerosis, coronary thrombosis, multiple sclerosis, the triopathy of diabetes mellitus, hypertension, and certain forms of malignant disease.

Various factors affect the dietary requirement of docosapentaenoic acid.
Docosapentaenoic Acid belongs to the class of organic compounds known as very long-chain fatty acids.
These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms.

Docosapentaenoic Acid is the all-cis-isomer of a C22 polyunsaturated fatty acid having five double bonds in the 7-, 10-, 13-, 16- and 19-positions.
Docosapentaenoic Acid has a role as a human metabolite and an algal metabolite.

Docosapentaenoic Acid is a conjugate acid of a (7Z,10Z,13Z,16Z,19Z)-docosapentaenoate.
Docosapentaenoic acid has been reported in Homo sapiens and Caenorhabditis elegans with data available.
Docosapentaenoic Acid is a polyunsaturated very long-chain fatty acid with a 22-carbon backbone and 5 double bonds, originating from the 3rd, 6th, 9th, 12th and 15th positions from the methyl end, with all double bonds in the cis- configuration.

Docosapentaenoic acid (DPA) C22:5, a polyunsaturated fatty acid.
All-cis-4,7,10,13,16-docosapentaenoic acid (osbond acid) is an omega-6 fatty acid.
All-cis-7,10,13,16,19-docosapentaenoic acid (clupanodonic acid) is an omega-3 fatty acid.

Docosapentaenoic acid (DPA) designates any straight open chain polyunsaturated fatty acid (PUFA) which contains 22 carbons and 5 double bonds.
Mammalian cells, including human cells, metabolize Docosapentaenoic Acid n-3 to an array of products that are members of the specialized proresolving mediators class of PUFA metabolites.

These metabolites include four resolvins of T series and three of D series (RvT1, RvT2, RvT3, RvT4, RvD1n-3, RvD2n-3, and RvD5n-3 (do not confuse with D series resolvins derived from DHA); see Specialized proresolving mediators § n-3 DPA-derived resolvins and Resolvin), two protectins (PD1n-3 and PD2n-3; see Specialized proresolving mediators § n-3 Docosapentaenoic Acid-derived protectins/neuroprotectins and Neuroprotectin), and three maresins (MaR1n-3, MaR2n-3, and MaR3n-3; see Specialized proresolving mediators § n-3 DPA-derived maresins and Maresin).

Docosapentaenoic acid (DPA) refers to a group of long-chain polyunsaturated fatty acids (PUFAs) with 22 carbon atoms and 5 double bonds.
These fatty acids occur naturally in marine oils and animal tissues and can belong to either the omega-3 (n-3) class or the omega-6 (n-6) class, depending on the position of the first double bond relative to the methyl end of the chain.

The most studied form, n-3 Docosapentaenoic Acid (also known as clupanodonic acid), is an intermediate product in the biosynthetic pathway from eicosapentaenoic acid (EPA) to docosahexaenoic acid (DHA) and has biological roles similar to other marine omega-3 fatty acids.
Docosapentaenoic Acid is being investigated for potential health effects including cardiovascular support and anti-inflammatory activity.

Docosapentaenoic acid (DPA) encompasses a family of very long-chain polyunsaturated fatty acids with 22 carbons and five double bonds.
The omega-3 form (22:5n-3) known as clupanodonic acid is a dietary and metabolic intermediate between EPA and DHA, present in fish oil and other marine sources.

Docosapentaenoic Acid is a hydrophobic, oily fatty acid with typical PUFA properties — insoluble in water, highly lipophilic, and biologically integrated into cell membranes.
Docosapentaenoic Acid contributes to membrane structure, participates in metabolic pathways that generate pro-resolving lipid mediators, and appears in nutritional supplements and research contexts.
As a nutrient, Docosapentaenoic Acid is considered safe within normal dietary and supplemental use.

USES and APPLICATIONS of DOCOSAPENTAENOIC ACID:
Docosapentaenoic acid is an Omega-3 fatty acid found in fish oils.
Docosapentaenoic Acid is a minor constituent of the total serum unsaturated fatty acids in humans, ranging from 0.1 to 1%, and increases on dietary supplementation.

Docosapentaenoic Acid (DPA) may not be as well-known as its omega-3 fatty acid relatives, EPA and DHA, but it's still essential for your health.
Found in cold-water fatty fish and mother's milk, Docosapentaenoic Acid helps support the normal growth and function of your brain and nervous system.

Docosapentaenoic Acid also plays a part in keeping your heart healthy.
What's great about Docosapentaenoic Acid is that it can change into either EPA or DHA when needed, making it a valuable nutrient for your body.
DPA is primarily used to designate two isomers, all-cis-4,7,10,13,16-docosapentaenoic acid (i.e. 4Z,7Z,10Z,13Z,16Z-docosapentaenoic acid) and all-cis-7,10,13,16,19-docosapentaenoic acid (i.e. 7Z,10Z,13Z,16Z,19Z-docosapentaenoic acid).

They are also commonly termed n-6 Docosapentaenoic Acid and n-3 Docosapentaenoic Acid, respectively; these designations describe the position of the double bond being 6 or 3 carbons closest to the (omega) carbon at the methyl end of the molecule and is based on the biologically important difference that n-6 and n-3 PUFA are separate PUFA classes, i.e. the omega-6 fatty acids and omega-3 fatty acids, respectively.

Mammals, including humans, can not interconvert these two classes and therefore must obtain dietary essential PUFA fatty acids from both classes in order to maintain normal health (see essential fatty acids).
Functional Food Ingredients: Marine oils rich in Docosapentaenoic Acid are used in functional foods and fortified nutritional products, especially where a broad spectrum of omega-3 fatty acids is desired.

Research & Biomarkers: Pure Docosapentaenoic Acid standards are used in nutritional research and lipidomics, to quantify DPA levels in biological samples, study fatty acid metabolism, or investigate metabolic roles in health and disease.
Docosapentaenoic acid is used as a nutritional component due to its role as an omega-3 polyunsaturated fatty acid involved in human health.

Docosapentaenoic Acid is applied in dietary supplements to support cardiovascular health by helping regulate lipid metabolism and reduce inflammation.
Docosapentaenoic acid is used in clinical and biomedical research to study its effects on inflammation pathways, cell signaling, and membrane fluidity.

Docosapentaenoic Acid has applications in neuroscience research because it contributes to brain structure, neuronal function, and cognitive development.
In prenatal and maternal nutrition, docosapentaenoic acid is used to support fetal brain and visual development.

Docosapentaenoic Acid is applied in the formulation of functional foods aimed at improving metabolic health and immune response.
Docosapentaenoic acid is used in pharmaceutical research as a potential therapeutic agent for inflammatory and cardiovascular diseases.
Docosapentaenoic Acid has applications in sports nutrition to support muscle recovery and reduce exercise-induced inflammation.

In cosmetic and dermatological products, docosapentaenoic acid is used for its skin barrier–supporting and anti-inflammatory properties.
Docosapentaenoic Acid is also used in aquaculture and animal feed formulations to improve growth, health, and fatty acid profiles of farmed species.

-Nutrition & Dietary Supplements use of Docosapentaenoic Acid:
Docosapentaenoic Acid is found naturally in fish and marine oils.
Although usually present in lower amounts than EPA and DHA, Docosapentaenoic Acid is included in many omega-3 supplements marketed to support heart health, inflammation resolution, and overall wellness.
Docosapentaenoic Acid may contribute to desirable fatty acid profiles in formulations that also contain EPA and DHA.

HISTORICAL USE of DOCOSAPENTAENOIC ACID:
Docosapentaenoic Acid, as an isolated nutrient, has no direct traditional or herbal use, as it was only identified and studied in the 20th century.
However, the foods naturally high in Docosapentaenoic Acid—especially marine fats—have been central to the diets and health of traditional populations for centuries.

In particular:
Inuit and other Arctic Indigenous peoples, whose diets were rich in seal and whale fat, consumed significantly more Docosapentaenoic Acid than typical Western populations.

These communities had historically low rates of cardiovascular disease and chronic inflammation, likely due in part to their high intake of all three major omega-3s:
EPA, Docosapentaenoic Acid, and DHA.
In traditional European diets, consumption of organ meats and fatty fish also provided Docosapentaenoic Acid, although this was never identified or differentiated from other fats at the time.

Today, Docosapentaenoic Acid is gaining attention in clinical nutrition and research for its unique role in cardiovascular repair, inflammation resolution, and omega-3 metabolism, particularly in advanced fish oil supplements and anti-inflammatory protocols.
Docosapentaenoic Acid is also being explored for neuroprotection, metabolic health, and exercise recovery.

FUNCTIONAL & BIOLOGICAL CHARACTERISTICS of DOCOSAPENTAENOIC ACID:
Docosapentaenoic acid is part of the family of omega-3 and omega-6 polyunsaturated fatty acids, important for membrane structure and function.
The n-3 form (clupanodonic acid) derived from dietary sources such as fish oil, marine oils, and seal oil, is incorporated into phospholipids of cell membranes in many tissues.
Like EPA and DHA, Docosapentaenoic Acid can influence cell signaling, inflammation, and lipid metabolism.

Human cells metabolize n-3 DPA into a variety of specialized pro-resolving mediators (SPMs), which play roles in resolving inflammation and supporting normal physiological processes.
Functionally, Docosapentaenoic Acid acts as a precursor to other long-chain omega-3 fatty acids and participates in lipid metabolic pathways along with EPA and DHA.
Docosapentaenoic Acid's presence in membranes affects fluidity, signaling cascades, and possibly cardiovascular and immune functions.

DOCOSAPENTAENOIC ACID IS FOUND IN:
*Cold-water fatty fish such as salmon, herring, and mackerel
*Seal and whale blubber (traditional sources for Inuit populations)
*Small amounts in human breast milk and tissues

*Some algae- or fish-derived omega-3 supplements, particularly those labeled as “full-spectrum”
Though not as widely studied as EPA or DHA, Docosapentaenoic Acid has its own distinct and valuable properties:
*Docosapentaenoic Acid supports cardiovascular health by reducing triglycerides, improving endothelial function, and reducing platelet aggregation

*Docosapentaenoic Acid enhances the body’s anti-inflammatory capacity, often acting synergistically with EPA and DHA
*Docosapentaenoic Acid functions as a lipid mediator precursor, involved in producing resolvins and protectins, compounds that help resolve inflammation

*Docosapentaenoic Acid appears to help repair damaged blood vessels and may inhibit the accumulation of atherosclerotic plaques
*Docosapentaenoic Acid may play a role in brain health and development, though more research is needed compared to DHA
*Some research suggests that Docosapentaenoic Acid may reconvert into EPA or DHA as needed, allowing it to serve as a reservoir for both major omega-3s, making it a flexible and multifunctional component of omega-3 supplementation.

ALTERNATIVE PARENTS of DOCOSAPENTAENOIC ACID:
*Unsaturated fatty acids
*Straight chain fatty acids
*Monocarboxylic acids and derivatives
*Carboxylic acids
*Organic oxides
*Hydrocarbon derivatives
*Carbonyl compounds

SUBSTITUENTS of DOCOSAPENTAENOIC ACID:
*Very long-chain fatty acid
*Unsaturated fatty acid
*Straight chain fatty acid
*Monocarboxylic acid or derivatives
*Carboxylic acid
*Carboxylic acid derivative
*Organic oxygen compound
*Organic oxide
*Hydrocarbon derivative
*Organooxygen compound
*Carbonyl group
*Aliphatic acyclic compound

PROPERTIES & BENEFITS of DOCOSAPENTAENOIC ACID:
Docosapentaenoic acid exhibits characteristics typical of omega-3 PUFAs:
*Membrane Integration:
Highly unsaturated structure promotes incorporation into cell membranes, affecting fluidity and receptor function.

*Precursor to Bioactive Lipids:
Metabolized to specialized pro-resolving mediators (SPMs) with roles in resolving inflammation.

*Physiological Functions:
May influence cardiovascular health, lipid metabolism, immune responses, and cellular signaling, similar to other long-chain omega-3s.

*Intermediate Metabolite:
Docosapentaenoic Acid acts as a biochemical bridge between EPA and DHA in metabolic pathways.
Research suggests potential benefits including modulation of inflammation and effects on gut microbiota composition, but clinical effects in humans require more evidence for firm conclusions.

NUTRITION of DOCOSAPENTAENOIC ACID:
Docosapentaenoic acid (DPA) is an n-3 fatty acid that is structurally similar to eicosapentaenoic acid (EPA) with the same number of double bonds, but two more carbon chain units.

DIETARY SOURCES of DOCOSAPENTAENOIC ACID:
These are the top five sources for Docosapentaenoic Acid according to the USDA Agricultural Research Service:
*Fish oil, menhaden 0.668 g in 1 tbsp. (13.6 g)
*Fish oil, salmon 0.407 g in 1 tbsp. (13.6 g)
*Salmon, red (sockeye), filets with skin, smoked (Alaska Native) 0.335 g in 1 filet (108 g)
*Fish, salmon, Atlantic, farmed, raw 0.334 g in 3 oz (85 g)
*Beef, variety meats and by-products, brain, cooked, simmered 0.326 g in 3 oz (85 g)
*Seal meat and human breast milk are rich in DPA

FUNCTIONS of DOCOSAPENTAENOIC ACID:
Clupanodonic acid, an omega-3 fatty acid, along with its metabolite DHA and other long chain omega-3 fatty acids, is under study to determine properties of omega-3 fats in humans, such as in inflammation mechanisms.

ISOMERS of DOCOSAPENTAENOIC ACID:
For nomenclature, see Essential fatty acid § Nomenclature and terminology.
The two isomers osbond acid and clupanodonic acid have the same number of double bonds, but on different positions along the chain, so they are regioisomers.

all-cis-4,7,10,13,16-docosapentaenoic acid (osbond acid)
n-6 DPA is an ω-6 fatty acid with the trivial name osbond acid.
It is formed in two steps from eicosatetraenoic acid (5,8,11,14-20:4n-6 or arachidonic acid, AA).
Arachidonic acid is elongated to docosatetraenoic acid (7,10,13,16-22:4n-6 or adrenic acid, AdA), which in turn is converted by Δ4-desaturase to osbond acid.

all-cis-7,10,13,16,19-docosapentaenoic acid (clupanodonic acid)
n-3 DPA is an n-3 fatty acid with the trivial name clupanodonic acid.
It is an intermediate compound between eicosapentaenoic acid (EPA 5,8,11,14,17-20:5n-3 or timnodonic acid) and docosahexaenoic acid (DHA 4,7,10,13,16,19-22:6n-3 or cervonic acid) in the metabolic pathway of DHA in eucaryotes.
Eicosapentaenoic acid is elongated to clupanodonic acid, which in turn is converted by Δ4-desaturase to docosahexaenoic acid 22:6n-3 (see Docosahexaenoic acid § Biosynthesis).

PHYSICAL and CHEMICAL PROPERTIES of DOCOSAPENTAENOIC ACID:
Preferred Name: Docosapentaenoic acid (n-3)
IUPAC Name: (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoic acid
Molecular Formula: C22H34O2
Molecular Weight: 330.5 g/mol
CAS Number: 24880-45-3
PubChem CID: 5497182
State & Appearance: Liquid oil
Solubility: Practically insoluble in water, soluble in organic solvents and lipids
Density: 0.9 g/cm3

Boiling Point: 442–443 °C
Flash Point: 338–340 °C
Log P: 6–7
pKa: 4.5–4.6
Molecular Weight: 330.5 g/mol
XLogP3-AA: 6.7
Hydrogen Bond Donor Count: 1
Hydrogen Bond Acceptor Count: 2

Rotatable Bond Count: 15
Exact Mass: 330.255880323 Da
Monoisotopic Mass: 330.255880323 Da
Topological Polar Surface Area: 37.3 Å²
Heavy Atom Count: 24
Formal Charge: 0
Complexity: 425
Isotope Atom Count: 0
Defined Atom Stereocenter Count: 0
Undefined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 5
Undefined Bond Stereocenter Count: 0
Covalently-Bonded Unit Count: 1
Compound Is Canonicalized: Yes
Chemical Formula: C22H34O2
Average Molecular Weight: 330.5042

Monoisotopic Molecular Weight: 330.255880332
IUPAC Name: (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoic acid
Traditional Name: clupanodonic acid
CAS Registry Number: 24880-45-3
SMILES: CCC=C/CC=C/CC=C/CC=C/CC=C/CCCCCC(O)=O
InChI Identifier: InChI=1S/C22H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-
InChI Key: YUFFSWGQGVEMMI-JLNKQSITSA-N

FIRST AID MEASURES of DOCOSAPENTAENOIC ACID:
-Description of first-aid measures
*General advice:
Show this material safety data sheet to the doctor in attendance.
*If inhaled:
After inhalation:
Fresh air.
*In case of skin contact:
Take off immediately all contaminated clothing.
Rinse skin with
water/ shower.
*In case of eye contact:
After eye contact:
Rinse out with plenty of water.
Call in ophthalmologist.
Remove contact lenses.
*If swallowed:
After swallowing:
Immediately make victim drink water (two glasses at most).
Consult a physician.
-Indication of any immediate medical attention and special treatment needed.
No data available

ACCIDENTAL RELEASE MEASURES of DOCOSAPENTAENOIC ACID:
-Environmental precautions:
Do not let product enter drains.
-Methods and materials for containment and cleaning up:
Cover drains.
Collect, bind, and pump off spills.
Observe possible material restrictions.
Take up dry.
Dispose of properly.
Clean up affected area.

FIRE FIGHTING MEASURES of DOCOSAPENTAENOIC ACID:
-Extinguishing media:
*Suitable extinguishing media:
Carbon dioxide (CO2)
Foam
Dry powder
*Unsuitable extinguishing media:
For this substance/mixture no limitations of extinguishing agents are given.
-Further information:
Prevent fire extinguishing water from contaminating surface water or the ground water system.

EXPOSURE CONTROLS/PERSONAL PROTECTION of DOCOSAPENTAENOIC ACID:
-Control parameters:
--Ingredients with workplace control parameters:
-Exposure controls:
--Personal protective equipment:
*Eye/face protection:
Use equipment for eye protection.
Safety glasses
*Body Protection:
protective clothing
*Respiratory protection:
Recommended Filter type: Filter A
-Control of environmental exposure:
Do not let product enter drains.

HANDLING and STORAGE of DOCOSAPENTAENOIC ACID:
-Conditions for safe storage, including any incompatibilities:
*Storage conditions:
Tightly closed.
Dry.

STABILITY and REACTIVITY of DOCOSAPENTAENOIC ACID:
-Chemical stability:
The product is chemically stable under standard ambient conditions (room temperature).
-Possibility of hazardous reactions:
No data available